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Objective: Economic evaluation typically is conducted using health state utilities to estimate treatment benefits.
However, such outcomes are often missing from studies of clinical effectiveness. This study aims to bridge that gap
by providing appropriate methods to link values from the Western Ontario and McMaster Universities Osteoarthritis
Index (WOMAC) to the EQ-5D utility instrument.
Method: Patients from a large registry of Spanish patients (n = 7072 observations) with knee or hip osteoarthritis
who completed both WOMAC and EQ-5D was used. A mixture model approach was used based on distributions
bespoke to the EQ-5D UK value set to estimate EQ-5D as a function of WOMAC pain, stiffness and function
subscores.
Results: A five class mixture model provides very close fit to the observed data at all levels of disease severity. The
overall mean (0.542 vs 0.542), median (0.620 vs 0.636) and the percentage of observations at full health (15 vs 14.8)
were very similar between the observed data and the estimated model respectively. Stiffness has limited
relationship to EQ-5D, whereas functional disability and pain are strong predictors.
Conclusion: EQ-5D can be reliably estimated from WOMAC subscale scores without any systematic bias using
these results.
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Osteoarthritis is one of the leading causes of pain and
limitation in function, typically affecting the hip, knee
and small hand joints. It is the most common form of
arthritis and is characterised by extreme variability in
clinical presentation, rate of disease progression and pa-
tient outcomes.
One of the most widely reported outcome measures in
Knee and Hip osteoarthritis is the Western Ontario and
McMaster Universities Osteoarthritis Index (WOMAC)
[1]. WOMAC comprises 24 questions covering the di-
mensions of pain, stiffness and physical functioning. With
substantial evidence of psychometric validity it is in wide-
spread use in clinical studies designed to assess the effi-
cacy of technologies in this disease area.
However, WOMAC is not a tool suitable for use in eco-
nomic evaluation. In particular, whilst analysts typically* Correspondence: a.j.wailoo@sheffield.ac.uk
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reproduction in any medium, provided the orseek to evaluate interventions in terms of costs and Qual-
ity Adjusted Life Years (QALYs), the scores from the
WOMAC instrument are not appropriate since they do
not provide either a cardinal or preference based scale.
Generic instruments that would facilitate the calculation
of benefits in terms of QALYs, such as the EQ-5D, Health
Utilities Index Mark 3 and SF-6D, have rarely been in-
cluded in clinical studies. There is therefore often a gap in
the evidence.
One method of bridging this evidence gap is by using
statistical methods to estimate the relationship between
clinical outcomes, such as WOMAC, and measures suit-
able for use in economic evaluation, using separate data-
sets of patients that have completed both instruments.
This allows the benefits of treatment to be converted to
an appropriate scale for economic evaluation. This prac-
tice has been variously labelled “mapping”, “cross-walking”
and “transfer to utility”.
However, utility data exhibit peculiar characteristics
that raise statistical challenges: they are limited at fullLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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that upper bound, they are limited below at the worst
health state described. EQ-5D tends to be bi or tri-
modal with a gap between full health and the next feas-
ible health state. Standard regression methods are not
suited to data with such distributions and the resulting
bias has been demonstrated in many disease areas [2,3]
and is evidenced in the published evidence on WOMAC
and osteoarthritis [4,5]. This bias leads to the systematic
undervaluing of the benefits of health care technologies
in economic evaluations, and ultimately to inappropriate
decisions for patients and their treating clinicians.
Barton et al. [5] (n = 348), Xie et al. [6] (n = 258),
Marshall et al. [4] and Grootendorst et al. [7] (n = 2186)
all use linear regression to estimate health state utilities
(either based on the EQ-5D or HUI-3) from the
WOMAC instrument. Barton et al. [5] (Figure 1) and
Marshall et al. [4] (Figures 1a and b), which takes
model results from Grootendorst et al. [7], present re-
sults that show how the fit of the statistical model var-
ies across the range of disease severity and, as expected
a priori, there is clear evidence of systematic bias: the
models overpredict utility values for patients with rela-
tively severe disease and underpredict values for those
patients at higher levels of health.
New methods have been developed specifically for
modelling EQ-5D and been demonstrated to overcome
the limitations of standard methods in other disease
areas [8]. This paper reports on the application of such
methods to modelling EQ-5D from WOMAC and other
explanatory variables using data from patients with
osteoarthritis of the hip or knee.
Methods
Dataset
A total of 1768 patients were recruited to this registry
study conducted in 15 hospitals from three regions of
Spain: 3 in Andalusia, 3 in the Canary Islands, and 9 inFigure 1 Distribution of EQ-5D summary scores.the Basque Country. The Institutional Review Boards of
each hospital approved the study.
Consecutive patients scheduled to undergo primary
joint replacement surgery due to knee or hip osteoarthritis
in one of the participating hospitals between October
2005 and October 2006 and who received postoperative
management in the hospitals were eligible for the study.
Patients with cancer or severe organic or psychiatric
diseases were excluded because these conditions could
prevent them from completing all the questionnaires in-
cluded in the study.
All patients were sent a letter informing them about
the study and asking for their voluntary participation.
Questionnaires were mailed to each patient at baseline
prior to surgery, 3, 6 and 12 months after surgery. Re-
minder letters were sent 15 days after each mailing to
patients who had not replied promptly. The baseline
questionnaire included items about expectations for
the operation, along with the SF-12, WOMAC, and
EQ-5D-3L questionnaires, plus questions requesting
sociodemographic information like gender, age, hos-
pital, weight and height (for the calculation of body
mass index [BMI]).
A total of 7072 observations were obtained.
We applied the EQ-5D UK tariff for use in this ana-
lysis. The Western Ontario and McMaster Universities
Osteoarthritis Index (WOMAC) is one of the most
widely reported outcome measured in clinical studies of
osteoarthritis. It comprises 24 questions with responses
to each given on a Likert scale: none (0), mild (1), mod-
erate (2), severe (3) or extreme (4) problems. It is pos-
sible to construct a single index score between 0–96 by
summing the scores to each question or one may con-
sider subscale scores based on pain (5 questions yielding
a range of 0–20), stiffness (2 questions range 0–8) and
functional impairment (17 questions range 0–68).
Statistical methods
Health state utility values in general, and the EQ-5D in-
strument in particular, are characterised by several fea-
tures that render standard statistical models redundant.
Feasible values are limited both above and below at full
health and the worst health state described by the in-
strument. There tend to be a large number of individuals
that indicate they are at full health. There is a relatively
large gap from full health to the next feasible value
(0.883). The typical distribution of EQ-5D tends to be
tri-modal with distinctly non-normal elements within
each section. In this situation it is obvious that standard
multiple regression models, which assume conditional
normality, are inappropriate. There now exists a battery
of studies that consistently demonstrate this to be the
case in a range of disease areas. Linear regression leads
to estimates that are consistently biased downwards
Table 1 Characteristics of the patient sample
Variable Obs Mean SD Min Max
Age (yrs) 1593 69.14 9.81 25.64 100.04
Body Mass Index 1455 29.65 4.67 14.17 50.22
EQ-5D 1520 0.29 0.35 −0.594 1
WOMAC pain scale 1660 11.37 3.78 0 20
WOMAC stiffness scale 1657 4.70 1.95 0 8
WOMAC function scale 1664 43.85 11.83 0 68
Proportion - Osteoporosis of the
hip
1768 0.61 0.49
Proportion - Male 1764 0.39 0.49
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the EQ-5D scale.
We have previously developed a method specifically
designed to produce appropriate estimates of EQ-5D
from clinical and other predictors. It has been dem-
onstrated to overcome the limitations of other com-
monly used direct and indirect methods in several
different settings and full details of the model are
provided elsewhere [8,9]. We apply this method here
in order to estimate EQ-5D from WOMAC responses,
incorporating other socio-demographic and clinical
covariate information.
The method applied here uses multiple regression with
two novel features. First, we use mixture models which
identify a number of different classes within the data
which when combined form a new distribution. Whilst
the individual classes may estimate EQ-5D as a function
of WOMAC and other variables based on standard dis-
tributional forms, when these are combined they can
form very complex, non standard distributions such as
the distribution of EQ-5D. Whilst the relationship be-
tween EQ-5D and each of the explanatory variables will
differ for each class it is not the identification of differ-
ent classes that leads us to use this framework, though
this may be a valuable insight. It is the flexibility of the
modelling framework that makes it particularly useful
for modelling EQ-5D values ([10]). The overall estimate
of EQ-5D, predicted from any set of WOMAC pain,
stiffness and disability scores, is a weighted function of
these individual components.
The second novel feature of the analysis is that, in this
case, instead of basing each separate class of the mixture
on a standard normal distribution, we base it instead on
a distribution specific to the characteristics of EQ-5D,
namely, limited above at full health (1), below at −0.594
and adjusted to reflect the gap in feasible values between
1 and 0.883.
Explanatory variables may enter the model in two
ways: either as predictors of the relationship with EQ-
5D within each of the individual classes, as in standard
regression, or as predictors of component membership.
We compared several different variants of using the ex-
planatory variables in these two ways. Within each class
we adopted a consistent approach to the inclusion of
variables, opting not to exclude non-significant terms on
an individual basis.
Results
Table 1 displays the characteristics of patients in the data-
set at baseline assessment and shows that there is substan-
tial variability across patients. Mean age is 69 years (sd
9.8) with a range of 25 to 100 years. The mean BMI of
29.7 (sd 4.7) is in the “overweight” category but patients
span all categories, from “underweight” to “obese”.WOMAC scale scores indicate that patients are of
moderate severity on average at baseline, as expected
from a hospital recruited cohort. Similarly mean EQ-5D
of 0.29 (sd 0.35) indicates a significant reduction in qual-
ity of life with patients spanning the entire feasible range
for the scale (−0.594 to 1). This is reflected in Figure 1
which provides a histogram of EQ-5D scores collected
over the 4 time points. This illustrates a distribution
with the classic characteristics of EQ-5D data: there is a
mass of observations at full health (1), a gap between
these observations and the rest, and at least two add-
itional modes. In total there are 598 observations, 8.5%
of the sample, at this upper limit.
We considered models with 3, 4 and 5 components.
The preferred model was a mixture of five components
on the basis of summary measures of fit (MAE, RMSE,
AIC, BIC) compared to standard linear regression and
mixtures with different numbers of components. Esti-
mates from the preferred model are shown in Table 2.
Within each class, we found that EQ-5D was best
explained by linear terms for WOMAC pain, stiffness
and function subscores. Pain was significantly and sub-
stantially negatively related to EQ-5D in class 2. In most
other classes the effect was not significant, except class
3 where a positive relationship was identified. Stiffness
has only a minor impact on predicting EQ-5D within
any of the classes: class 4 has a small negative relation-
ship (p < 0.1). Function has a much stronger relationship
with EQ-5D within all the classes. Coefficients are nega-
tive for all classes, this is statistically significant at the
10% level in 4 classes and almost significant in the
remaining class (class 2). The effect is greatest in class 3.
Pain, stiffness, function and their quadratic terms were
entered as predictors of class membership. Estimates are
also shown in Table 2. The probability of class 5 is 1
minus the sum of the probability of being in classes 1 to
4. Pain and function are important predictors of class
membership whilst stiffness is statistically significant
only as a determinant of class 2 membership.
Table 2 Parameter estimates from the 5 class mixture model
Class 1 Class 2 Class 3 Class 4 Class 5
Parameter p-value p-value p-value p-value p-value
Within class Pain/10 0.0166 0.260 −0.2357 0.000 *** 0.1475 0.000 *** 0.001 0.285 0.0116 0.600
Stiffness/10 0.0118 0.583 −0.0287 0.760 −0.0182 0.662 −0.0029 0.057 * 0.0037 0.914
Function/10 −0.0356 0.000 *** −0.0274 0.103 −0.07 0.000 *** −0.0003 0.087 * −0.0403 0.000 ***
Variance 0.0024 0.000 *** 0.0406 0.000 *** 0.0047 0.001 *** 0 0.000 *** 0.0058 0.002 ***
Random effects
terms
Intercept 0.7636 0.000 *** 0.3762 0.000 *** 0.9662 0.000 *** 0.555 0.000 *** 0.2118 0.000 ***
Age1 0.005 0.000 ***
Male 0.0083 0.000 ***
Variance 0.0016 0.000 ***
Class
probabilities
Intercept 8.8821 0.000 *** 7.0881 0.000 *** 11.4076 0.000 *** 5.1497 0.0004 ***
Pain/10 −5.1772 0.006 *** −7.9363 0.000 *** −13.4885 0.000 *** −6.4654 0.0006 ***
Stiffness/10 −1.0227 0.625 −6.1566 0.004 *** −0.7275 0.751 −1.0918 0.6023
Function/10 −1.3706 0.026 ** −0.9434 0.162 −2.0612 0.002 *** 0.37 0.5729
(Pain/10)2 1.2266 0.114 2.3464 0.001 *** 4.5149 0.000 *** 1.4951 0.0568 *
(Stiffness/10)2 −1.158 0.604 3.7049 0.156 −1.483 0.570 −1.3521 0.5465
(Function/10)2 0.0797 0.286 0.1946 0.008 *** 0.2545 0.001 *** −0.0626 0.4179
EQ-5D estimates
by class
Mean 0.678 0.124 0.881 0.557 0.106
Median 0.679 0.129 0.865 0.557 0.107
Min 0.307 −0.594 0.335 0.382 −0.377
Max 1 1 1 0.748 0.598
Proportion of ones 0.004 0.001 0.431 0.000 0.000
Prob of class
membership
0.333 0.109 0.240 0.146 0.172
Notes: 1Age = (age-mean age in sample)/10. Mean sample age is 69 years.
*: P<0.1, **: P<0.05, ***: P<0.01.
Table 3 Summary measures of performance
Data Mixture model Linear model
Mean 0.5422 0.5421 0.5402
Median 0.620 0.636 0.552
SD 0.363 0.361 0.361
Minimum −0.594 −0.594 −0.946
Maximum 1 1 1.942
Proportion of ones 15.02 14.81 1.121*
*The linear model is fully continuous. We have reported the proportion of
values >0.99 and < 1.01.
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ship and the impact of explanatory variables within each
class are partly due to the fact that each class is centred
around different elements of the disease severity
spectrum. The lower element of Table 2 provides statis-
tics describing the location and spread of each class.
Classes 2 and 5 are centred around the most severe pa-
tients with mean EQ-5D of approximately 0.1. This peak
in the overall distribution of EQ-5D scores is clearly vis-
ible in Figure 1. Class 2 has a much greater variance
however, spanning the entire feasible range of EQ-5D
(−0.594 to 1). Note that because the model is designed
bespoke to the features of EQ-5D it does not generate
values outside the feasible range. Classes 1, 3 and 4
jointly reflect the peaks in the distribution seen around
0.7 and 1. Class 1 is the largest of the groups and has a
mean EQ-5D of 0.68. Class 3 has a mean of 0.88 (the
upper limit of EQ-5D values below full health) but is the
only class that contributes a substantial proportion of
full health observations.
Table 3 illustrates that for the mixture model overall,
the mean value is virtually identical to the observed data.
Similarly, the range of the data is equivalent to the data,by design. For the sake of comparison the liner regres-
sion equivalent is provided. The mean is quite close to
the data for this model but other values illustrate how
the model assumptions of conditional normality lead to
poorer reflection of the overall distribution. In particular,
the model predicts values that substantially exceed the
feasible EQ-5D range, both above full health and below
the “pits” state.
Figure 2 compares the mean fitted EQ-5D values from
the mixture model against the mean EQ-5D across the
range of WOMAC disease severity for the summary
Figure 2 Mean EQ-5D by mean a) total WOMAC, b) WOMAC pain, c) WOMAC stiffness and d) WOMAC function, overall and by
individual class.
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subscale (Figure 2c) and function subscale (Figure 2d).
The plots illustrate that the expected values generated
from the statistical model fit the data extremely closely
across the entire range of disease severity, however se-
verity is defined. There is no evidence of systematic
bias in the model fit.
The figures also illustrate the expected values for the
individual classes. There is clear variation in the slopes
for each class. Class 4 is the least responsive to changes
in disease severity whilst class 2 is the most responsive.
Note that this is not simply a reflection of the within
class coefficients since patients with greater levels of dis-
ease severity on one measure also tend to have greater
levels of impairment on other measures. None of the
slopes are as steep as for the combined relationship
which is formed as the weighted average of the five clas-
ses with the weights themselves a function of disease se-
verity. The overall slope at low levels of impairment is
formed predominantly from classes 1 and 3, whereas atthe most severe levels of impairment it is formed from
classes 2 and 5.
Discussion
Whilst several previous studies have been published that
look at the relationship between some measure of health
utility and the WOMAC instrument, they are all based
on linear regression models (Xie et al. [6] include a com-
parison with the Censored Least Absolute Deviations
(CLAD) model). Theoretically these are unlikely to be
appropriate, have been shown to be biased in many
other disease areas, and also appear to be biased in the
osteoarthritis setting [4,5]. Studies have also been based
on relatively small samples of patients.
In this paper we have applied a method based on mix-
ture models that suffers from none of these problems,
using data of over 7,000 patient observations that cover
the full spectrum of disease. It therefore provides an ap-
propriate method to express treatment benefits from
clinical studies which use the WOMAC as an outcome
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and economic outcomes is increasingly important for re-
imbursement authorities. This is therefore not just of
academic interest. Patients and their treating clinicians
are directly affected by the methods used to estimate
QALYs. To assist those wishing to use these results we
provide an online calculator in Excel that provides pre-
dicted EQ-5D scores for any user-defined set of WOMAC
inputs, age and sex (see Additional file 1).
We find that the stiffness component of WOMAC is
relatively unimportant in determining EQ-5D values, con-
sistent with Barton et al. [5] and Grootendorst et al. [7].
Pain and functional disability are much more strongly as-
sociated with changes in health utilities but these relation-
ships are different between five classes of patients,
identifiable from their disease characteristics. Whether
disease was of the hip or the knee did not impact the rela-
tionships we identified.
Mitchell et al. [11] recently report a “mapping” study
linking to the recently developed ICECAP-0 capabilities
measure which, whilst anchored around a 0–1 scale, is
not a health utility based instrument. The study only
considers linear models on the basis that there are only
a small number of observations at the maximum value.
Whether the spread of values in the dataset truly repre-
sents the spread of severity requires consideration but in
any case, the performance of the mixture model ap-
proach advocated here in the context of health state util-
ity values should also be considered in the context of
other outcome measures such as ICECAP.
Our analysis is based on single sample of Spanish pa-
tients receiving a variety of treatments within the broad
spectrum of standard practice. In using the results, consid-
eration must be given as to whether this sample includes
these for the decision problem at hand and whether the
specific treatments under consideration might in some
way change the relationship between pain, stiffness, func-
tion and health utility.
Conclusions
EQ-5D can be reliably estimated from WOMAC sub-
scale scores without any systematic bias by using the re-
sults presented here.
Additional file
Additional file 1: EQ-5D calculator.
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